Manlangit, Baby Boy .
HRN: 26-44-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/15/2025
MUPIROCIN 2%, 15G (TUBE)
01/15/2025
01/22/2025
SKIN
0.5mg
BID
Phlebitis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes